Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arild Holth

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Cytopathology : Official Journal of the British Society for Clinical Cytology|April 2, 2025
The Diagnostic Role of TFF1, TFF3, FOXA1, CA XII and TRPS1 in Serous EffusionsBen Davidson, Arild Holth, Jeremias Wohlschlaeger, et al.
The Breast Journal|July 29, 2008
The chemokine receptor CXCR4 is more frequently expressed in breast compared to other metastatic adenocarcinomas in effusionsBen Davidson, Hiep Phuc Dong, Arild Holth, et al.
Diagnostic Cytopathology|August 19, 2007
Flow cytometric immunophenotyping of cancer cells in effusion specimens: diagnostic and research applicationsBen Davidson, Hiep Phuc Dong, Arild Holth, et al.
Virchows Archiv : an International Journal of Pathology|June 14, 2020
Death domain-associated protein (DAXX) expression is associated with poor survival in metastatic high-grade serous carcinomaBen Davidson, Erin McFadden, Arild Holth, et al.
Cytometry. Part B, Clinical Cytometry|January 18, 2007
Flow cytometric immunphenotyping of epithelial cancer cells in effusions--technical considerations and pitfallsHiep P Dong, Arild Holth, Aasmund Berner, et al.
Human Pathology|April 29, 2008
Claudin upregulation in ovarian carcinoma effusions is associated with poor survivalLilach Kleinberg, Arild Holth, Claes G Trope, et al.
Gynecologic Oncology|March 25, 2019
SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinomaMiriam Sherman-Samis, Hadil Onallah, Arild Holth, et al.
American Journal of Clinical Pathology|April 19, 2007
Chemokine receptors are infrequently expressed in malignant and benign mesothelial cellsBen Davidson, Hiep Phuc Dong, Arild Holth, et al.
Human Pathology|February 15, 2011
Osteopontin expression in ovarian carcinoma effusions is related to improved clinical outcomeBen Davidson, Arild Holth, Leni Moripen, et al.
Virchows Archiv : an International Journal of Pathology|November 24, 2018
Expression and clinical role of the dipeptidyl peptidases DPP8 and DPP9 in ovarian carcinomaMarta Brunetti, Arild Holth, Ioannis Panagopoulos, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Cytopathology : Official Journal of the British Society for Clinical Cytology|April 2, 2025
The Diagnostic Role of TFF1, TFF3, FOXA1, CA XII and TRPS1 in Serous EffusionsBen Davidson, Arild Holth, Jeremias Wohlschlaeger, et al.
The Breast Journal|July 29, 2008
The chemokine receptor CXCR4 is more frequently expressed in breast compared to other metastatic adenocarcinomas in effusionsBen Davidson, Hiep Phuc Dong, Arild Holth, et al.
Diagnostic Cytopathology|August 19, 2007
Flow cytometric immunophenotyping of cancer cells in effusion specimens: diagnostic and research applicationsBen Davidson, Hiep Phuc Dong, Arild Holth, et al.
Virchows Archiv : an International Journal of Pathology|June 14, 2020
Death domain-associated protein (DAXX) expression is associated with poor survival in metastatic high-grade serous carcinomaBen Davidson, Erin McFadden, Arild Holth, et al.
Cytometry. Part B, Clinical Cytometry|January 18, 2007
Flow cytometric immunphenotyping of epithelial cancer cells in effusions--technical considerations and pitfallsHiep P Dong, Arild Holth, Aasmund Berner, et al.
Human Pathology|April 29, 2008
Claudin upregulation in ovarian carcinoma effusions is associated with poor survivalLilach Kleinberg, Arild Holth, Claes G Trope, et al.
Gynecologic Oncology|March 25, 2019
SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinomaMiriam Sherman-Samis, Hadil Onallah, Arild Holth, et al.
American Journal of Clinical Pathology|April 19, 2007
Chemokine receptors are infrequently expressed in malignant and benign mesothelial cellsBen Davidson, Hiep Phuc Dong, Arild Holth, et al.
Human Pathology|February 15, 2011
Osteopontin expression in ovarian carcinoma effusions is related to improved clinical outcomeBen Davidson, Arild Holth, Leni Moripen, et al.
Virchows Archiv : an International Journal of Pathology|November 24, 2018
Expression and clinical role of the dipeptidyl peptidases DPP8 and DPP9 in ovarian carcinomaMarta Brunetti, Arild Holth, Ioannis Panagopoulos, et al.
Pageof 6